Daglyfy 100 mg/10 mg filmom obložene tablete
| Name | Daglyfy 100 mg/10 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-781459585 |
| Active Substance | sitagliptinfosfat hidrat dapagliflozin propandiol hidrat |
| Composition | jedna filmom obložena tableta sadrži 100 mg sitagliptina (u obliku sitagliptinfosfat hidrata) i 10 mg dapagliflozina (u obliku dapagliflozin propandiolhidrata) |
| Pharmaceutical Form | Filmom obložena tableta |
| Manufacturer | TAD Pharma Gmbh, Cuxhaven, Njemačka
Krka d.d. Novo mesto, Novo Mesto, Slovenija |
| Marketing Authorisation Holder | Krka d.d. Novo mesto, Šmarješka cesta 6, Novo Mesto, Slovenija |
| Marketing Authorisation Date | 09.04.2025 |
| MA Period of Validity | 09.04.2030 |
| Classification Number | UP/I-530-09/23-01/354 |
| Registration Number | 381-12-01/171-25-07 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product on medical prescription for renewable delivery |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | A10BD29 |
| Marketing status | Never marketed |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
